- Hong Kong
- /
- Healthcare Services
- /
- SEHK:1951
Jinxin Fertility Group (HKG:1951) Is Reinvesting At Lower Rates Of Return
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. However, after briefly looking over the numbers, we don't think Jinxin Fertility Group (HKG:1951) has the makings of a multi-bagger going forward, but let's have a look at why that may be.
What Is Return On Capital Employed (ROCE)?
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Jinxin Fertility Group:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.013 = CN¥162m ÷ (CN¥14b - CN¥1.3b) (Based on the trailing twelve months to June 2025).
So, Jinxin Fertility Group has an ROCE of 1.3%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 6.7%.
Check out our latest analysis for Jinxin Fertility Group
In the above chart we have measured Jinxin Fertility Group's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Jinxin Fertility Group .
The Trend Of ROCE
In terms of Jinxin Fertility Group's historical ROCE movements, the trend isn't fantastic. To be more specific, ROCE has fallen from 4.1% over the last five years. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.
The Bottom Line
To conclude, we've found that Jinxin Fertility Group is reinvesting in the business, but returns have been falling. Moreover, since the stock has crumbled 71% over the last five years, it appears investors are expecting the worst. All in all, the inherent trends aren't typical of multi-baggers, so if that's what you're after, we think you might have more luck elsewhere.
Jinxin Fertility Group could be trading at an attractive price in other respects, so you might find our free intrinsic value estimation for 1951 on our platform quite valuable.
While Jinxin Fertility Group may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1951
Jinxin Fertility Group
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
Good value with moderate growth potential.
Market Insights
Community Narratives


